The market size of Acute Kidney Injury in the United States was USD 2,907 Million in 2017.
The United States recorded 895,078 cases of Acute Kidney Injury in 2017, while Germany had registered around 82,902 diagnosed cases during the same period.
The key companies in the Acute Kidney Injury market include Exponential Biotherapies, Alloksys, Angion Biomedica Corp, Quark Pharmaceuticals, AM Pharma, Atox Bio, Astellas Pharma, Orion Pharma, MediBeacon, Pharming and others.
For more detailed information visit at: https://www.delveinsight.com/report-store/acute-kidney-injury-aki-market#infographics
Acute Kidney Injury (AKI) Market Size & Share 2030
Acute Kidney Injury Aki Market DelveInsight's "Acute Kidney Injury (AKI) - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Acute Kidney Injury (AKI), historical and forecasted epidemiology as well a
www.delveinsight.com